Anemia in the Elderly: How Should We Define It, When Does It Matter, and What Can Be Done?

Steensma, David P.; Tefferi, Ayalew
August 2007
Mayo Clinic Proceedings;Aug2007, Vol. 82 Issue 8, p958
Academic Journal
Anemia signifies an underlying disease and is associated with poor clinical outcomes. In elderly patients, in whom anemia has a high prevalence (>10%), neither the hemoglobin threshold for concern nor the identity of the anemia-causing disease is easily established. This is an important shortfall, because even mild anemia can compromise patients' well-being and survival, regardless of the underlying cause. This review discusses definitions of ‘normal’ hemoglobin levels in adults, common causes of anemia in people aged 65 years and older (eg, nutritional deficiency, renal insufficiency, inflammatory disorders, and myelodysplastic syndrome), and potential consequences of anemia in elderly patients (eg, poorer cognitive status, increased frailty, and an elevated risk of hospitalization and of complications during hospitalization). We also outline a practical initial diagnostic approach that helps determine appropriate treatment, and we weigh therapeutic options in light of new safety concerns regarding erythropoiesis-stimulating agents.


Related Articles

  • Erythropoietins in cancer patients: ESMO Recommendations for use. Greil, R.; Thödtman, R.; Roila, F. // Annals of Oncology;May2008 Supplement 2, Vol. 19 Issue 0, pii113 

    The article presents the clinical recommendations of the European Society for Medical Oncology (ESMO) for the use of erythropoietins in cancer patients. Anemia is a cancer characterized by a decrease of hemoglobin level below normal lower limit either related to disease or therapy. Data on the...

  • Myelodysplastic Syndromes--Many New Drugs, Little Therapeutic Progress. Tefferi, Ayalew // Mayo Clinic Proceedings;Nov2010, Vol. 85 Issue 11, p1042 

    In this article, the author discusses the myelodysplastic syndromes (MDS) which constitute a form of blood cancer that primarily affects the elderly and characterized by anemia and high risk of leukemic transformation. The author is critical on the establishment of a robust Mayo Clinic health...

  • Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function. Castelli, Roberto; Deliliers, Giorgio; Colombo, Riccardo; Moreo, Guido; Gallipoli, Paolo; Pantaleo, Giuseppe // Annals of Hematology;Sep2014, Vol. 93 Issue 9, p1523 

    The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders characterized by bone marrow failure and a risk of progression to acute myeloid leukemia (AML). Anemia affects the course of disease, quality of life (QOL), and cognitive function of MDS patients....

  • Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype. Starczynowski, Daniel T.; Kuchenbauer, Florian; Argiropoulos, Bob; Sung, Sandy; Morin, Ryan; Muranyi, Andrew; Hirst, Martin; Hogge, Donna; Marra, Marco; Wells, Richard A.; Buckstein, Rena; Lam, Wan; Humphries, R. Keith; Karsan, Aly // Nature Medicine;Jan2010, Vol. 16 Issue 1, p49 

    5q– syndrome is a subtype of myelodysplastic syndrome characterized by severe anemia and variable neutropenia but normal or high platelet counts with dysplastic megakaryocytes. We examined expression of microRNAs (miRNAs) encoded on chromosome 5q as a possible cause of haploinsufficiency....

  • Anemia was independently associated with mortality in very old persons. Steensma, David P. // ACP Journal Club;12/15/2009, Vol. 151 Issue 6, p11 

    The article presents information about a population-based cohort study which reports that anemia increases the risk of death in very old persons, independent of comorbid conditions. 562 inhabitants of 85 years were selected from Leiden, the Netherlands. The study shows that low hemoglobin levels...

  • Anämie im Alter. Röhrig, G.; Schulz, R.J. // Zeitschrift für Gerontologie und Geriatrie;Apr2012, Vol. 45 Issue 3, p182 

    The prevalence of anemia in the elderly is high and can reach among independent community-dwelling persons > 20% and among hospitalized geriatric patients up to 40%. Anemia in the elderly has numerous causes rather than being clearly age related. Although it is widely acknowledged that anemia...

  • PREVALENCE OF ANAEMIA IN OLDER IN-PATIENTS WITH SYMPTOMATIC CHRONIC HEART FAILURE. Chattopadhyay, I.; Bhowmick, B. K. // Age & Ageing;May2004 Supplement 1, Vol. 33, pi8 

    Presents an abstract of the study "Prevalence of Anaemia in Older In-Patients With Symptomatic Chronic Heart Failure," by I. Chattopadhyay and B. K. Bhowmick.

  • An MPL W515L mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis: A case report. LIN HAO; SANDEEP SEN; DHIVYA SUGUMAR // Oncology Letters;2015, Vol. 9 Issue 2, p749 

    The current study presents the case of a 63-year-old patient exhibiting refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), who was positive for the MPL W515L mutation, but negative for the JAK2 V617F mutation. Following diagnosis, the patient remained...

  • Anemia, heart failure linked.  // Geriatrics;Oct2005, Vol. 60 Issue 10, p11 

    Discusses research being done on the link between anemia and heart failure in older people. Reference to a study published in the 2005 issue of the journal "Circulation"; Decline in the level of hemoglobin among patients; Percentage of increase in risk of death and complications due to anemia...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics